Biocon Biologics
-
Business
Eris to buy Biocon arm’s branded drugs for 1,242 crore – Times of India
[ad_1] NEW DELHI: Biocon is selling branded formulations of its subsidiary Biocon Biologics to Eris Lifesciences for Rs 1,242 crore.…
Read More » -
Business
Biocon subsidiary grants distribution of biosimilar to Sandoz in Japan – Times of India
[ad_1] NEW DELHI: Biocon Biologics, a subsidiary of Biocon has signed a distribution agreement with Sandoz, granting the company exclusive…
Read More » -
Business
Eris to buy Biocon arm’s brands in Rs 366 crore deal – Times of India
[ad_1] NEW DELHI: Biocon Biologics (BBL) is divesting its dermatology and nephrology branded formulations business to Eris Lifesciences for Rs…
Read More »
